Ring Therapeutics Unveils Cutting-Edge Gene Therapy Platforms at ASGCT 2026 Conference#USA#Cambridge#gene_therapy#ASGCT_2026#Ring_Therapeutics
Ring Therapeutics Unveils Cutting-Edge Gene Therapy Platforms at ASGCT 2026 Conference
Ring Therapeutics has introduced groundbreaking technologies, Vector Conjugate and VectorBricks™ platforms, at the ASGCT 2026 conference, showcasing their potential for gene therapy advancements.
third-news.com
May 14, 2026 at 10:18 AM
Ring Therapeutics Unveils Cutting-Edge Gene Therapy Platforms at ASGCT 2026 Conference#USA#Cambridge#gene_therapy#ASGCT_2026#Ring_Therapeutics